JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, A.
Right arrow Articles by Trendelenburg, U.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Jones, A.
Right arrow Articles by Trendelenburg, U.
Journal of Pharmacology And Experimental Therapeutics, Vol. 139, Issue 3, 312-320, 1963
Copyright © 1963 by American Society for Pharmacology and Experimental Therapeutics


THE PRESSOR RESPONSE OF THE SPINAL CAT TO DIFFERENT GROUPS OF GANGLION-STIMULATING AGENTS

Ann Jones 1, B. Gomez Alonso de la Sierra 1, and U. Trendelenburg 1

1 Department of Pharmacology, Harvard Medical School, Boston, Massachusetts

Intravenous injections of McN-A-343 and AHR-602 caused a transient fall and then a pronounced secondary rise of blood pressure. Ganglion block by depolarization, established by large amounts of nicotine or tetramethylammonium (TMA), abolished the pressor response to McN-A-343 and AHR-602; however, during the phase of "non-depolarizing ganglion block by nicotine" McN-A-343 and AHR-602 caused a marked pressor response at a time when nicotine and dimethylphenylpiperazinium (DMPP) produced no response. The pressor response to McN-A-343 and AHR-602 was potentiated after large amounts of nicotine, and hexamethonium subsequently reduced the response to the expected control magnitude.

Cocaine, morphine and methadone reduced the blood pressure rise caused by McN-A-343 and AHR-602 but were ineffective against nicotine and DMPP. Block of transmitter release from adrenergic nerve endings by TM 10 also prevented the pressor response to McN-A-343 and AHR-602.

It is concluded that the secondary rise of blood pressure caused by the intravenous injection of McN-A-343 and AHR-602 is due to an action of these agents on sympathetic ganglia. While stimulation of the adrenal medulla seems to be of some importance in the pressor response to McN-A-343, AHR-602 has a very weak action, if any, on the adrenal medulla and causes a pressor response mainly by the stimulation of sympathetic ganglion cells. McN-A-343 and AHR-602 resemble pilocarpine in their pharmacology and seem to produce stimulation of ganglia by an action on receptors different from those for nicotine and DMPP.

Submitted on October 31, 1962
Accepted on December 14, 1962







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1963 by the American Society for Pharmacology and Experimental Therapeutics.